Updates

DOSE OF REALITY: BRAND NAME DRUG MAKERS INCREASINGLY UTILIZING ‘USE CODES’ TO GAME PATENT SYSTEM AND BLOCK COMPETITION

Sep 30, 2024

STAT Analysis Finds Drug Makers Gaming FDA Orange Book Process to Further Read More

DOSE OF REALITY: BIG PHARMA’S GLP-1 PRICE-GOUGING UNSUSTAINABLE FOR AMERICAN PATIENTS AND THE U.S. HEALTH SYSTEM

Sep 23, 2024

Brand Name Drug Companies Applying Price-Hiking, Patent Abuse Playbook to Read More

DOSE OF REALITY: BIG PHARMA SETS DRUG PRICES, HIKES DRUG PRICES AND BLOCKS COMPETITION TO KEEP DRUG PRICES HIGH

Sep 10, 2024

Lawmakers Should Focus on Holding Big Pharma Accountable for Egregious Pricing Read More

CSRxP JOINS FELLOW ADVOCATES FOR LOWER DRUG PRICES TO URGE HOUSE JUDICIARY COMMITTEE TO CRACK DOWN ON BIG PHARMA’S PATENT ABUSE

Sep 6, 2024

Letter Encourages Lawmakers to Advance Bipartisan Solutions to Hold Big Pharma Read More

They Said It! R Street Institute Expert Explains How Big Pharma Games The Patent System to Keep “Drug Prices Artificially High”

Sep 3, 2024

New Report Emphasizes The “Pharmaceutical Industry’s Patent Gamesmanship Read More

BIG PHARMA EARNINGS WATCH: ELI LILLY & AMGEN

Aug 26, 2024

Price Hikes and Egregious Prices on Blockbuster Drugs Boost Profits Read More

DOSE OF REALITY: BIG PHARMA’S EGREGIOUS GLP-1, GENE, AND CELL THERAPY PRICES PROJECTED TO INCREASE HEALTH CARE COSTS FOR EMPLOYERS

Aug 26, 2024

Analysis Finds GLP-1 Blockbusters and “Multimillion-Dollar Gene Therapies” Read More